Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Theravance Bio Ord (NQ: TBPH )

8.925 -0.175 (-1.92%)
Streaming Delayed Price Updated: 1:13 PM EDT, May 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Theravance Bio Ord

< Previous 1 2 3 4 5 Next >
The Daily Biotech Pulse: Early Approval For Ascendis' Pediatric Growth Hormone Deficiency Treatment, Redhill Biopharma Spikes On Positive COVID-19 Drug Data, RenovoRx IPO
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 25) Abbvie Inc. (NYSE: ABBV)... 
Via Benzinga
Exposures COVID-19
Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2021
Upgrades For Kite Realty Group Trust (NYSE: 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
On Wednesday morning, 17 companies hit new 52-week lows. Things to Consider: The largest company by market cap to set a new 52-week low was Campbell Soup (NYSE:CPB... 
Via Benzinga
10 Biggest Price Target Changes For Wednesday
Wells Fargo raised the price target for Urban Outfitters, Inc. (NASDAQ: 
Via Benzinga
The Daily Biotech Pulse: Lilly Strikes $1.6B R&D Collaboration, FSD Pulls Plug On COVID-19 Program, Cassava Sinks On Questions About Alzheimer's Drug
ere's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 24) Agenus Inc. (NASDAQ: AGEN)... 
Via Benzinga
Exposures COVID-19
60 Biggest Movers From Yesterday
Gainers Triple-S Management Corporation (NYSE: GTS) shares surged 45.5% to close at $35.20 on Tuesday. GuideWell Mutual Holding Corporation, parent of Blue Cross and Blue Shield... 
Via Benzinga
Here's Why Theravance Biopharma Stock Is Tanking Today
The company's second clinical-trial flop in as many months isn't sitting well with investors. 
Via The Motley Fool
Mid-Afternoon Market Update: Nasdaq Rises 75 Points; Palo Alto Networks Shares Jump On Upbeat Earnings
Toward the end of trading Tuesday, the Dow traded up 0.26% to 35,427.95 while the NASDAQ rose 0.50% to 15,018.26. The S&P also rose, gaining 0.25% to 4,490.82. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
Vaccine Optimism Pushes S&P 500, Nasdaq to Fresh Intraday Highs
This week is so far proving to be much better than the last one, as the three major indexes look to extend yesterday's gains. 
Via Talk Markets
Topics Stocks
Exposures US Equities
Analysts Slash Price Targets After Theravance's Failed Ulcerative Colitis Study
Analysts have lowered the price target and downgraded Theravance Biopharma Inc (NASDAQ: 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Triple-S Management (NYSE:GTS) shares moved upwards by 45.3% to $35.15 during Tuesday's regular session. As of 12:30 EST, Triple-S Management's stock is... 
Via Benzinga
Mid-Day Market Update: Crude Oil Rises Over 2%; Theravance Biopharma Shares Slide
Midway through trading Tuesday, the Dow traded up 0.09% to 35,368.20 while the NASDAQ rose 0.40% to 15,001.95. The S&P also rose, gaining 0.14% to 4,486.01. The U.S. has the... 
Via Benzinga
Topics Stocks
Exposures Fossil Fuels US Equities
What 10 Analyst Ratings Have To Say About Theravance Biopharma
Theravance Biopharma (NASDAQ:TBPH) has observed the following analyst rati... 
Via Benzinga
38 Stocks Moving In Tuesday's Mid-Day Session
Gainers Triple-S Management Corporation (NYSE: GTS) shares jumped 45.3% to $35.15. GuideWell Mutual Holding Corporation, parent of Blue Cross and Blue Shield of Florida Inc,... 
Via Benzinga
Mid-Morning Market Update: Markets Edge Higher; Best Buy Earnings Top Estimates
Following the market opening Tuesday, the Dow traded up 0.11% to 35,374.12 while the NASDAQ rose 0.43% to 15,006.17. The S&P also rose, gaining 0.22% to 4,489.23. The U.S. has... 
Via Benzinga
Topics Stocks
Exposures US Equities
Theravance Stock Crashes; Can Longer Testing Salvage Its J&J-Partnered Drug?
Theravance said late Monday its ulcerative colitis treatment failed in midstage testing, and the biotech stock plummeted early Tuesday. 
Via Investor's Business Daily
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday's morning trading, 20 companies set new 52-week lows. Noteables: The largest company in terms of market cap to set a new 52-week low was Campbell... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 24, 2021
Upgrades Canaccord Genuity upgraded the previous rating for Precision Drilling Corp (NYSE: 
Via Benzinga
10 Biggest Price Target Changes For Tuesday
Benchmark cut the price target for JD.com, Inc. (NASDAQ: 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Gainers Triple-S Management (NYSE:GTS) stock moved upwards by 44.27% to $34.9 during Tuesday's pre-market session. The market value of their outstanding shares is at $... 
Via Benzinga
Theravance Stock Plunges As JAK Inhibitor Flops Ulcerative Colitis Study
Theravance Biopharma Inc's (NASDAQ: TBPH) Izencitinib, a "gut-selective" JAK inhibitor developed for ulcerative colitis and Crohn's disease, failed a... 
Via Benzinga
Theravance Biopharma, inc (TBPH) Q2 2021 Earnings Call Transcript
TBPH earnings call for the period ending June 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Recap: Theravance Biopharma Q2 Earnings
Shares of Theravance Biopharma (NASDAQ:TBPH) were flat in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share rose 20.00% year over... 
Via Benzinga
The Daily Biotech Pulse: Cara's Korsuva Greenlighted By FDA, Clinical Trial Disappointments For Novartis, Theravance, Vertex Inks CRISPR Licensing Deal
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 23) AbbVie Inc. (NYSE: ABBV) (... 
Via Benzinga
Exposures Product Safety
Know When To Hold 'Em, Know When To Fold 'Em ...
A long Monday list identifying some sensible and some impenetrable moves behind today's market in our stocks. 
Via Talk Markets
Stocks That Hit 52-Week Lows On Monday
Before 10 a.m. ET Monday, 63 stocks made new 52-week lows. Intriguing Points: The largest company by market cap to set a new 52-week low was PACCAR (NASDAQ:PCAR).... 
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
Monday morning, 34 companies reached new 52-week lows. Things to Consider: Las Vegas Sands (NYSE:LVS) was the largest, in terms of market cap, to set a new 52-week... 
Via Benzinga
The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 2) Absci, CORP (NASDAQ: ABSI) (... 
Via Benzinga
Earnings Scheduled For August 3, 2021
Companies Reporting Before The Bell • Myriad Genetics (NASDAQ:MYGN) is likely to report earnings for its fourth quarter. • Stellantis (NYSE:STLA) is expected to... 
Via Benzinga
The Week Ahead In Biotech (Aug. 1-7): Biopharma Earnings Pick Up Pace, Eton Awaits FDA Decision, Focus On Pending Clinical Readouts and IPOs
Biotech stocks showed a lack of direction in the week ending July 30 amid earnings releases from big pharma companies. Most pharma majors reported strong quarterly results.... 
Via Benzinga
Exposures Product Safety
< Previous 1 2 3 4 5 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.